Table 1.
The distribution of cardiovascular medications consumption by urbanicity, data presented as mean ± (SD)a
| Population (%) | Group Ab | Group B | Group C | Group D | Group O | |
|---|---|---|---|---|---|---|
| Taipei-Keelung metropolitan area (N = 44) | 6,609,220 (29.4) | 32.2 (42.0) | 18.1 (22.1) | 32.3 (43.4) | 10.2 (12.8) | 2.7 (4.7) |
| Taoyuan-Chungli metropolitan area (N = 12) | 1,846,082 (8.2) | 40.9 (79.5) | 20.0 (34.9) | 40.4 (72.0) | 11.7 (23.9) | 2.4 (2.8) |
| Hsinchu secondary metropolitan Area (N = 10) | 682,132 (3.0) | 18.2 (15.9) | 11.0 (9.2) | 21.2 (18.4) | 6.1 (5.7) | 1.1 (1.1) |
| Taichung-Changhwa metropolitan area (N = 18) | 2,092,344 (9.3) | 41.7 (60.3) | 24.1 (33.2) | 45.6 (71.5) | 13.5 (20.6) | 3.5 (4.4) |
| Chiayi secondary metropolitan area (N = 4) | 373,774 (1.7) | 36.5 (42.8) | 19.5 (19.6) | 40.1 (49.5) | 13.1 (17.6) | 4.3 (5.9) |
| Tainan metropolitan area (N = 14) | 1,246,084 (5.5) | 27.1 (26.7) | 15.6 (14.6) | 31.7 (32.9) | 7.2 (7.4) | 2.7 (3.8) |
| Kaohsiung metropolitan area (N = 28) | 2,758,140 (12.2) | 43.9 (94.0) | 23.0 (37.8) | 45.7 (82.5) | 12.5 (24.6) | 3.7 (4.5) |
| Rural townships area (N = 167) | 6,100,872 (27.1) | 18.2 (18.2) | 10.7 (10.4) | 19.3 (21.1) | 5.7 (7.8) | 1.6 (2.9) |
| Aboriginal townships area (N = 55) | 812,703 (3.6) | 25.3 (26.5) | 10.4 (10.6) | 19.6 (22.7) | 7.7 (9.5) | 1.3 (3.4) |
| Total (N = 352) | 22,521,351 (100) | 25.7 (40.8) | 13.9 (19.1) | 26.0 (40.3) | 7.9 (12.7) | 2.1 (3.6) |
a. Data presented as DDD/1000 inhabitants per day
b. Group A, agents acting on the rennin-angiotensin system; Group B, beta blocking agents; Group C, calcium channel blockers; Group D, diuretics; Group O, antihypertensives